4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0000899243-16-034297
CIK 0001566373operating
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:01 PM ET
Size
6.7 KB
Accession
0000899243-16-034297
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Award
Warrant (right to buy)
2016-11-23+13,150→ 13,150 totalExercise: $10.79From: 2017-05-24Exp: 2021-11-23→ Common Stock (13,150 underlying) - Award
Common Stock
2016-11-23$9.12/sh+13,150$119,928→ 53,300 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:01 PM ET
- Size
- 6.7 KB